Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,823 | 11,557 | 16,428 | 25,009 | 22,011 |
| Receivables | 1,900 | 6,285 | 4,778 | 2,686 | 3,369 |
| TOTAL | $42,883 | $19,049 | $22,866 | $29,555 | $26,830 |
| Non-Current Assets | |||||
| PPE Net | 159 | 174 | 190 | 181 | 207 |
| Other Non-Current Assets | 353 | 399 | 444 | 498 | 542 |
| TOTAL | $512 | $573 | $634 | $679 | $749 |
| Total Assets | $43,395 | $19,622 | $23,500 | $30,234 | $27,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 827 | 771 | 1,821 | 1,984 | 1,895 |
| Accrued Expenses | 3,923 | 9,372 | 7,708 | 7,620 | 9,505 |
| Other current liabilities | 1,736 | 2,023 | 1,227 | 1,345 | 1,117 |
| TOTAL | $6,654 | $12,364 | $10,950 | $11,142 | $12,705 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 212 | 229 | 280 | 342 | 392 |
| TOTAL | $212 | $229 | $280 | $342 | $392 |
| Total Liabilities | $6,866 | $12,593 | $11,230 | $11,484 | $13,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,274 | 73,472 | 61,993 | 61,973 | 41,548 |
| Common Shares | 88 | 65 | 62 | 60 | 41 |
| Retained earnings | -195,304 | -190,374 | -183,640 | -175,160 | -167,318 |
| TOTAL | $36,529 | $7,029 | $12,270 | $18,750 | $14,482 |
| Total Liabilities And Equity | $43,395 | $19,622 | $23,500 | $30,234 | $27,579 |